Term
|
Definition
- Age: teens - 20
- # of sexual partners
- Prostitution
- Illicit drug use
- Sexual preference
|
|
|
Term
Uncomplicated Gonorrhea: Clinical Presentation |
|
Definition
- Urethral infection -- dysuria and urinary frequency, purulent discharge
- Anorectal infection -- severe rectal, pruritus, bleeding
- Pharyngeal infection -- mild pharyngitis
- Abnormal vaginal discharge, uterine bleeding
|
|
|
Term
Complicated Gonorrhea: Clinical Presentation |
|
Definition
Pelvic Inflammatory Disease
Disseminated gonorrhea
|
|
|
Term
Uncomplicated Gonorrhea Treatment: w/o allergies to beta-lactam |
|
Definition
Ceftriaxone 125 mg IM x 1 dose
OR
Cefixime 400 mg PO x 1 dose
+
Azithromycin 1 g x 1 dose |
|
|
Term
Uncomplicated Gonorrhea Treatment: With allergies to beta-lactam |
|
Definition
Azithromycin 2 g PO x 1 dose (emerging resistance)
|
|
|
Term
Complicated Gonorrhea Treatment: Disseminated |
|
Definition
Ceftriaxone IV or IM until improvement begins, then Ceftriaxone PO regimen x 7 days |
|
|
Term
Complicated Gonorrhea Treatment: Pregnancy |
|
Definition
Cephalosporin
OR
Azithromycin |
|
|
Term
Primary Syphilis: Clinical Presentation |
|
Definition
Incubation
10-90 days
Site of infection
External genitalia, perianal region, mouth, throat
Signs/Symptoms
Chancre sore, regional lymphadenopathy |
|
|
Term
Secondary Syphilis: Clinical Presentation |
|
Definition
Incubation
2-8 weeks
Site of Infection
Multisystem involvement
Signs/Symptoms
Pruritic or nonpruritic rash, mucocutaneous lesion, flu-like symptoms |
|
|
Term
Latent Syphilis: Clinical Presentation |
|
Definition
Incubation
4-10 weeks (after secondary)
Site of Infection
Multisystem involvement (dormant)
Signs/Symptoms
Asymptomatic |
|
|
Term
Tertiary Syphilis: Clinical Presentation |
|
Definition
Incubation
10-30 years
Site of Infection
CNS, heart, eyes, bones, joints
Signs/Symptoms
Cardiovascular syphilis, gumma lesions present, neurosyphilis |
|
|
Term
Primary Syphilis: Treatment/Follow up |
|
Definition
Benzathine PCN G IM
RPR at 6 and 12 months |
|
|
Term
Secondary Syphilis: Treatment/Follow up |
|
Definition
Benzathine PCN G IM
RPR at 6 and 12 months |
|
|
Term
Early Latent Syphilis: Treatment/Follow up |
|
Definition
Benzathine PCN G IM
RPR at 6 and 12 months |
|
|
Term
Late Latent Syphilis: Treatment/Follow up |
|
Definition
Benzathine PCN G IM weekly x 3 weeks
OR
Aqueous crystalline PCN G IV infusion x 10-14 days
RPR at 6, 12, and 24 months |
|
|
Term
Neurosyphilis: Treatment/Follow up |
|
Definition
Benzathine PCN G IM weekly x 3 weeks
OR
Aqueous crystalline PCN G IV infusion x 10-14 days
CSF examination q 6 months until clear |
|
|
Term
Jarisch-Herxheimer Reaction |
|
Definition
- Acute febrile reaction of unknown MOA
- NOT an allergic reaction
- Flu-like symptoms: HA, myalgias, tachypnea, malaise
- Develops 2-24 hrs post PCN dose
- Tx: antipyretics, analgesics, and rest
|
|
|
Term
Primary Syphilis Treatment: PCN Allergic Patients |
|
Definition
Doxycycline
OR
Tetracycline
OR
Ceftriaxone |
|
|
Term
Secondary Syphilis Treatment: PCN Allergic Patients |
|
Definition
Doxycycline
OR
Tetracycline
OR
Ceftriaxone |
|
|
Term
Early Latent Syphilis Treatment: PCN Allergic Patients |
|
Definition
Doxycycline
OR
Tetracycline
OR
Ceftriaxone |
|
|
Term
Late Latent or Unknown Duration Syphilis Treatment: PCN Allergic Patients |
|
Definition
Doxycycline
OR
Tetracycline
OR
Ceftriaxone |
|
|
Term
Uncomplicated Chlamydia: Clinical Presentations |
|
Definition
- Usually asymptomatic
- Urethral discharge (watery)
- Abnormal vaginal discharge
- Dysuria
- Mild pharyngitis
|
|
|
Term
Complicated Chlamydia: Clinical Presentations |
|
Definition
PID
Infertility
Reiter Syndrome |
|
|
Term
Uncomplicated Chlamydia: Treatment |
|
Definition
Azithromycin 1 g PO x 1 dose
OR
Doxycycline 100 mg PO BID x 7 days
Abstain from sexual intercourse x 7 days post treatment |
|
|
Term
Pelvic Inflammatory Disease: Risk Factors |
|
Definition
Young Age
Use of IUD
Poor socioeconomic status |
|
|
Term
Pelvic Inflammatory Disease: Clinical Presentations |
|
Definition
Results from untreated chlamydia or untreated gonorrhea
- Pelvic pain
- Lower abdominal tenderness
- Cervical motion tenderness
- Oral Temp > 101 F
- Abdominal Cervical / Vaginal Discharge
- Elevated erythrocyte sedimentation rate
- Elevated C reactive protein
- LAb verification of Chlamydia or Gonorrhea
|
|
|
Term
Pelvic Inflammatory Disease: Treatment |
|
Definition
PO Outpatient Regimens
Ofloxacin x 14 days
OR
Levofloxacin x 14 days
+
Metronidazole x 14 days
OR
Ceftriaxone x 1 dose
+
Doxycycline x 14 days
Parenteral Inpatient Regimen
Cefoxitin IV + Doxycycline IV |
|
|
Term
|
Definition
- Primary mucocutaneous infection
- Infection of the ganglia
- Establishment of latency
- Reactivation (through physical/emotional stress)
- Recurrent infection
|
|
|
Term
Genital Herpes: Clinical Presentation |
|
Definition
- Asymptomatic (primary infection)
- Prodrome: mild burning, itching, tingling
- Multiple painful pustular or ulcerative lesions (usually heal in 2-4 weeks)
- Flu-like symptoms (fever, HA, malaise)
|
|
|
Term
Genital Herpes: Treatment of First Clinical Episode |
|
Definition
Palliative (not curative)
Acyclovir x 7-10 days
OR
Famciclovir x 7-10 days
OR
Valacyclovir x 7-10 days
|
|
|
Term
Genital Herpes: Treatment of Recurrent Infections |
|
Definition
Chronic Suppressive Tx (> 6 episodes/year):
Acyclovir
OR
Famciclovir
OR
Valacyclovir |
|
|
Term
Genital Herpes: Episodic Treatment |
|
Definition
Acyclovir 400 mg PO TID x 5 days
OR
Acyclovir 800 mg PO BID x 5 days
OR
Acyclovir 800 mg PO TID x 2 days
OR
Famciclovir 125 mg PO TID x 5 days
OR
Valacyclovir 500 mg PO BID x 5 days
OR
Valacyclovir 1 g PO QD x 5 days |
|
|
Term
Genital Herpes: Resistance to 1st Line Antivirals |
|
Definition
|
|
Term
Herpes Antivirals: MOA, AEs |
|
Definition
MOA
- Inhibit DNA synthesis and viral replication of herpes virals
- Only active against replicating virus
AE
Famciclovir: N/D, HA, fever, dizziness fatigue
Valacyclovir: N/V/D, HA, abdominal pain, dizziness
Acyclovir: N/V/D, HA, lethargy, dizziness, rash, nephrotoxicity |
|
|
Term
Uncomplicated Trichomoniasis: Clinical Presentation |
|
Definition
Females:
Scant to copious, malodorous vaginal discharge
Pruritis
Males:
Often asymptomatic
Urethral discharge (clear to mucopurulent) |
|
|
Term
Complicated Trichomoniasis: Clinical Presentation |
|
Definition
- PID
- Premature labor
- Infertility (male and female)
- Cervical neoplasia
|
|
|
Term
Trichomoniasis: Treatment |
|
Definition
Metronidazole 2 g PO x 1 dose
OR
500 mg Po BID x 7 days
OR
Tinidazole 2 g PO x 1 dose |
|
|
Term
Metronidazole: Counseling, AE, CI |
|
Definition
- May take with food to decrease GI upset
- Use 7 day course in those with severe GI complaints
- Treat sexual partners simultaneously
AE
- N/V/D
- Abdominal pain
- HA
- Dizziness
- Dry mouth
- Metallic taste
Avoid EtOH:
- During treatment and 3 days post completion of therapy
- Can Cause Disulfiram-Like Rxn: N/V, HA, flushing, abdominal cramps
|
|
|
Term
|
Definition
- Consider with metronidazole-resistant trichomoniasis
- Better tolerated than metronidazole
AE
- Nausea
- Dyspepsia
- Metallic/bitter taste
Avoid EtOH:
- During treatment and 3 days post completion of therapy
- Can Cause Disulfiram-Like Rxn: N/V, HA, flushing, abdominal cramps
|
|
|
Term
Human Papillomavirus 6 is associated with: |
|
Definition
Development of genital warts |
|
|
Term
Human Papillomavirus 11 is associated with: |
|
Definition
Development of genital warts |
|
|
Term
Human Papillomavirus 16 is associated with: |
|
Definition
Increased risk of cervical neoplasia |
|
|
Term
Human Papillomavirus 18 is associated with: |
|
Definition
Increased risk of cervical neoplasia |
|
|
Term
|
Definition
Cryotherapy with liquid nitrogen or surgical removal for external warts
Patient Applied Therapy:
Podofilox sol'n or gel
Imiquimod cream |
|
|
Term
|
Definition
- HPV Vaccine
- Marketed for females (9-26 yrs)
- Stimulates antibody protection against 4 types of HPV (6, 11, 16, 18)
|
|
|
Term
|
Definition
- Injection site reactions (pain and swelling)
- HA, fever, fatigue
- Fainting
- VTE: risk factors include concurrent OC uses, genetic predisposition to blood clots
- Not recommended in pregnant patients
|
|
|
Term
Expedited Partner Therapy |
|
Definition
- Eligible patients: lab evaluation indicates + Chlamydia or Gonorrhea, sexual partner exposure within 60 days
- Re-testing: 3 months after treatment
- Treatment Recommendations:
Azithromycin
OR
Cefixime |
|
|
Term
Herpes Simplex Virus (HSV) - 1 |
|
Definition
|
|
Term
Herpes Simplex Virus (HSV) - 2 |
|
Definition
|
|